High Prevalence of Lung Cancer in Developed Economies to Fuel Demand for Lung Cancer Therapeutics Market, Says TMR

According to the report, the rising adoption of personalized medicines will give significant impetus to the global lung cancer therapeutics market. On the flip side, patent expiry of blockbuster drugs pose a major threat to the market. Nevertheless, the launch of novel therapeutics could bolster opportunities for the lung cancer therapeutics manufacturers in the forthcoming years.

Read More: http://www.transparencymarketresearch.com/lung-cancer-therapeutics-markets.html

0 rating(s) (0 ø)
Views: 43

All rights reserved

• This document may not be used, copied nor changed without explicit consent of the author.
Copyright Icon
The maximum length of a comment is 1000 characters.
The maximum length of an alias is 30 characters.
Please enter a comment.
Please insert a valid comment!